measuregroup/AID100819

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID374263482_AID100819_PMID12852768_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103338662_AID100819_PMID12852768_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103168783_AID100819_PMID12852768_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID124974065_AID100819_PMID12852768_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103338330_AID100819_PMID12852768_VALUE3
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID360
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antiproliferative activity against L1210 phenotype L1210 VCR tumor cell line
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103338662 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103168783 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID124974065 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103338330 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID374263482
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID100819

Total number of triples: 15.